Dr Reddy's hits all-time high ahead of Jan-March earnings

Shares in Dr Reddy’s Laboratories gained as much as 2.9 percent to an all-time high of Rs 2,152 on hopes the Indian drugmaker will beat earnings estimates for the March quarter by a wide margin, according to multiple dealers.

They cite market speculations that Dr.Reddy’s will report a net profit of over Rs 500 crore for the January-March period versus analyst estimates of Rs 446 crore as provided by Thomson Reuters StarMine.

[caption id=“attachment_777101” align=“alignleft” width=“380”] They cite market speculations that Dr.Reddy’s will report a net profit of over Rs 500 crore. Reuters[/caption]

Dr Reddy’s shares up 0.54 percent at 1:34 p.m.

The company spokesman refrained from comment.

Reuters